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Pinhas Sarelia, Jan A. Staessenc and Angela J. WoodiwissaAim The relationship between waist circumference (WC)
and conventional blood pressure (BP) is independent of
other clinical indices of adiposity. As ambulatory BP may
offer more prognostic information than conventional BP, we
aimed to identify whether indices of central adiposity are
associated with ambulatory BP independent of other
indices of adiposity.
Methods The relationship between indices of adiposity
[WC, waist-to-hip ratio, body mass index (BMI) or skin-fold
thickness] and ambulatory or conventional BP was
determined in 300 randomly selected individuals of African
descent living in an urban developing community in South
Africa. Relationships were determined with multiple indices
of adiposity in the same regression model and after
adjusting for age, gender, alcohol and tobacco intake, the
presence or absence of diabetes mellitus or inappropriate
blood glucose control [haemoglobin A1c (HbA1c)],
antihypertensive therapy and menopausal status.
Results Sixty-five per cent of participants were overweight
or obese. With respect to the relationships between indices
of adiposity, BMI and WC showed the strongest correlation
(r U 0.84, P < 0.0001). After including all indices of adiposity
and confounders in the model, WC was the only clinical
index of adiposity which independently predicted 24-h
(partial r U 0.15, P < 0.005) and conventional (partial r U 0.14,
P < 0.005) systolic BP and 24-h (partial r U 0.13, P < 0.02)opyright © Lippincott Williams & Wilkins. Unautho
0263-6352  2007 Lippincott Williams & Wilkinsand conventional (partial r U 0.40, P < 0.0001) diastolic BP.
After adjusting for other adiposity indices and confounders,
every 1 SD (15 cm) increase in WC resulted in a 4.04 mmHg
increase in 24-h systolic BP and a 4.33 mmHg increase in
24-h diastolic BP. Similar results were obtained in the
subgroup of 237 participants not receiving antihypertensive
therapy.
Conclusion WC is the only clinical index of adiposity that is
associated with 24-h and conventional BP independent of
other adiposity indices in a community with a high
prevalence of obesity. J Hypertens 25:1798–1806 Q 2007
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The prevalence of obesity is rapidly increasing in both
developed [1] and developing [2] countries. There is now
substantial evidence from large population-based studies
in favour of excess adiposity being a major determinant of
blood pressure (BP) and the development of hypertension
[3–5]. In this regard, present evidence suggests that waist
circumference (WC) appears to be the preferred clinical
index when relating adiposity to conventional BP [3–16];
however, to our knowledge studies that have compared the
relative impact of indices of central fat and body mass
index (BMI) on ambulatory BP have either recruited small
study samples, have been non-random, have focused on
waist-to-hip ratio rather than WC as the index of central fat,
and have produced ambiguous results [17–21]. As 24-h
ambulatory BP is a better index of cardiovascular outcomes[22–25] and target organ effects [26] than conventional BP
values, the relative impact of indices of central and general
adiposity on ambulatory BP requires elucidation. In the
present study we assessed whether any one commonly
used clinical index of adiposity (WC, waist-to-hip ratio,
BMI and skin-fold thickness) predicts ambulatory BP
independent of the others. This study was conducted in
a randomly selected population sample, with a high preva-
lence of obesity, living in an urban developing community
in South Africa.
Methods
Study subjects
The protocol of the study was approved by the University
of the Witwatersrand Committee for Research in Human
Subjects (approval number: M02-04-72). Participantsrized reproduction of this article is prohibited.
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African Project on Genes in Hypertension. The population
sample has recently been described [27]. Since the initial
analysis, a larger study sample has been recruited. Briefly,
nuclear families were recruited if at least one or two
offspring of at least 16 years of age and one or both parents
were available for examination. Of 496 South African
individuals of African ancestry randomly recruited from
metropolitan areas of Johannesburg, 395 had all the
required clinical data. Of these, 300 had more than 20 h
of ambulatory BP recordings and more than 10 and
five readings for the computation of daytime and night-
time means, respectively.
Clinical, demographic and anthropometric
measurements
A standardized questionnaire was administered to obtain
demographic data and information on each participant’s
medical history, smoking habits, intake of alcohol, use of
medication, and menopausal status. Height and weight
were measured with the participants standing and wear-
ing indoor clothes with no shoes. BMI was calculated as
weight in kilograms divided by the square of height in
metres. Waist and hip circumference were measured
using a standard approach, and triceps and subscapular
skin-fold thickness determined using a skinfold calliper
(Harpenden skinfold calliper). Skin-fold thickness was
reported as the mean of triceps and subscapular values.
Subjects were identified as being overweight if their BMI
was 25 kg/m2 and obese if their BMI was 30 kg/m2.
Standard laboratory blood tests of renal function, liver
function and haematological parameters were performed
to ensure that subjects did not have subclinical renal,
hepatic or haematological disorders. Diabetes mellitus or
inappropriate blood glucose control was defined as the
use of insulin or oral hypoglycaemic agents, or a percent-
age glycated haemoglobin (HbA1c) (Roche Diagnostics,
Mannheim, Germany) >7% [28]. Follicular stimulating
hormone (Bayer, Leverkusen, Germany) was measured
to confirm menopausal status. To determine 24-h urine
Naþ excretion (an index of Naþ intake), timed urine
samples were obtained over a period of at least 24 h after
discarding urine excreted immediately prior to the start of
the collection period. Urine Naþ concentrations were
measured and 24-h urine Naþ excretion rate calculated
from the product of urine volume and urine Naþ concen-
tration. The quality of the urine samples was determined
as described previously [29,30].
Conventional blood pressure measurements
Trained observers measured brachial artery BP in a clinic
environment using a mercury sphygmomanometer. The
conventional BP measurement was obtained on the
same day as ambulatory BP monitors were initialized.
The participants were seated and asked to rest for
5 min. The observers measured the participants’ sitting
BP five consecutive times. Systolic and diastolic (phase V)opyright © Lippincott Williams & Wilkins. UnauthBP were determined to the nearest 2 mmHg, according to
the recommendations of the European Society of Hyper-
tension [31]. In most participants standard cuffs were used,
which had an inflatable bladder with a length of 22 cm and
a width of 12 cm. If arm circumference exceeded 31 cm,
larger cuffs with a 31 15 cm bladder were employed. The
five readings obtained at each of the visits were averaged to
obtain a single systolic and diastolic BP value. Hyperten-
sion was defined as the use of antihypertensive medication
or if the mean of five conventional BP measurements was
140/90 mmHg in those not receiving medication.
Ambulatory blood pressure measurements
Twenty-four-hour ambulatory BP monitoring was per-
formed using oscillometric monitors (SpaceLabs, model
90207; SpaceLabs, Redmond, Washington, USA). The
size of the cuff was the same as that used for conventional
BP measurements. The accuracy of ambulatory monitors
was checked monthly against a mercury manometer. If the
monitors recorded pressure values that deviated from a
mercury reading by more than 4 mmHg, monitors were
recalibrated by the commercial suppliers. The monitors
were programmed to measure BP at 15-min intervals from
0600 to 2200 h and then at 30-min intervals from 2200 to
0600 h. Participants kept a diary card for the duration of
the recordings to note the time of going to bed in the
evening and getting up in the morning. From each partici-
pant’s diary card data we determined the awake and asleep
periods. Considering the patterns of daily activities, the
daytime and night-time intervals were defined as time
intervals ranging from 0900 to 1900 h and from 2300 to
0500 h respectively. These fixed clock-time intervals
[32,33] were defined in order to eliminate the transition
periods (evening and morning) during which BP changes
rapidly in most subjects. Intra-individual means of the
ambulatory measurements were weighted by the time
interval between successive recordings [32,33]. Ambu-
latory BP data were expressed as 24-h, daytime and
night-time average systolic and diastolic BP. Daytime
and night-time periods were defined as described pre-
viously [32].
Data analysis
Database management and statistical analyses were per-
formed with SAS software, version 9.1 (SAS Institute
Inc., Cary, North Carolina, USA). Data from individual
subjects were averaged and expressed as meanSD.
Proportions were compared withx2 analysis. Linear regres-
sion analysis was used to determine relationships. Step-
wise regression analysis was performed to determine
independent effects of indices of adiposity on BP.
Included in the regression model were age, gender, alcohol
and tobacco intake (defined as the presence or absence of
daily tobacco or alcohol ingestion), postmenopausal status
(confirmed with follicle stimulating hormone measure-
ments), the presence or absence of diabetes mellitus or
inappropriate blood glucose control (considered as a singleorized reproduction of this article is prohibited.
C1800 Journal of Hypertension 2007, Vol 25 No 9covariate) and the use of antihypertensive therapy (either
receiving therapy or not receiving therapy). To identify
those indices of adiposity associated with BP independent
of other indices of adiposity, indices of adiposity were
considered together in the regression model. In addition to
including antihypertensive therapy as a covariate in the
regression analyses, sensitivity analyses were repeated in a
subgroup of subjects who were not receiving antihyper-
tensive therapy (n¼ 237).
Results
Characteristics of the participants
Table 1 gives the demographic and clinical characteristics
of the participants. More women than men participated
(Table 1). Sixty-five per cent of subjects were overweight
or obese, with 27.6% being overweight and 37.7% being
obese. In the group 42% were hypertensive, 20% were
receiving therapy for hypertension, and 8% had diabetes
mellitus (Table 1). A relatively small percentage of the
group were smokers (12%), mostly due to lack of afford-
ability and also due to the greater proportion of women
(who traditionally do not smoke in this population) com-
pared to men. Twenty-four-hour urine Naþ excretion rates
(an index of Naþ intake) despite being high, were
not associated with indices of obesity (r values: BMI¼
0.05; WC¼ 0.003; skin-fold thickness¼ 0.003; waist-to-
hip ratio¼ 0.11; P> 0.1 for all). The mean age (41.4
17.9 years) and BMI (28.9 7.3 kg/m2) and the percentage
of women (63%) in all individuals recruited was the sameopyright © Lippincott Williams & Wilkins. Unautho
Table 1 Demographic, anthropometric and clinical characteristics
of study subjects
All participants
Participants with
ambulatory BP
Sample number 395 300
% Female 63 63
Age (years) 41.818.1 43.017.9
Height (m) 1619 1619
Weight (kg) 7519 7519
BMI (kg/m2) 28.87.4 29.07.4
Waist circumference (cm) 8915 8915
Hip circumference (cm) 10715 10615
WHR 0.840.10 0.840.10
% Overweight/obese 65 66
Skin-fold thickness (cm)
Subscapular 2.411.37 2.471.36
Triceps 1.901.20 2.011.25
Mean 2.151.16 2.241.19
Urine Naþ excretion (mmol/day) 113.953.5 110.448.1
% smokers 12.2 12.7
% alcohola 21.2 22.3
% with hypertension 42.0 41.7
% treated for hypertension 20.3 21.0
% with DM 8.2 8.1
HbA1c (%) 6.021.07 6.041.07
n (%) postmenopausal 98 (39) 78 (41)
Clinic SBP/DBP (mm Hg) 13023/8412 13123/8412
Ambulatory BP (mmHg)
24 h SBP/DBP (mmHg) – 11916/7311
Daytime SBP/DBP (mmHg) – 12316/7811
Night-time SBP/DBP (mmHg) – 11218/6512
BMI, body mass index; BP, blood pressure; DBP, diastolic BP; DM, diabetes
mellitus; HbA1c, glycated haemoglobin; SBP, systolic BP; WHR, waist-to-hip ratio.
a Percentage of participants consuming alcohol on a daily basis.as that for participants with all clinical data (Table 1). The
demographic and clinical characteristics of the participants
with ambulatory BP measurements that met prespecified
quality control criteria were similar to those of participants
with all clinical data (Table 1). In addition, although they
were younger (38.1 16.5 years), fewer individuals had
hypertension (26.2%) and there were fewer postmenopau-
sal women (29%), the other demographic and clinical
characteristics in the subgroup of subjects not receiving
antihypertensive therapy (n¼ 237) did not differ from
those of either the participants with ambulatory BP meas-
urements or those with all clinical data (data not shown).
In the present study only 0.76% of visits had fewer than the
planned conventional BP recordings. The frequency of
identical consecutive conventional BP recordings was
0.25%. The occurrence of conventional BP values re-
corded as an odd number was 0% and of the 3936 systolic
and diastolic conventional BP readings, 27.8% ended on a
zero (expected¼ 20%). Average conventional systolic and
diastolic BP values were higher than average 24-h, daytime
or night-time systolic and diastolic BP values (Table 1).
Association between indices of adiposity
BMI and WC showed the strongest relationship. The
weakest relationship was noted between waist-to-hip
ratio and BMI. Furthermore, only a trend effect was
noted between waist-to-hip ratio and skin-fold thickness
(Table 2). Similar associations were evident in the sub-
group of participants who were not receiving antihyper-
tensive therapy (data not shown).
Unadjusted associations between indices of adiposity
and blood pressure
BMI, WC, waist-to-hip ratio and skin-fold thickness were
all correlated with conventional systolic BP (Fig. 1). BMI,
WC and waist-to-hip ratio, but not skin-fold thickness,
were correlated with 24-h systolic BP (Fig. 2). Significant
correlations between either BMI (r¼ 0.35, P< 0.0001),
WC (r¼ 0.41, P< 0.0001), waist-to-hip ratio (r¼ 0.27,
P< 0.0001) or skin-fold thickness (r¼ 0.25, P< 0.0001)
and conventional diastolic BP were also noted before
adjustments; whereas BMI (r¼ 0.17, P¼ 0.0031), WC
(r¼ 0.28, P< 0.0001) and waist-to-hip ratio (r¼ 0.23,
P< 0.0001), but not skin-fold thickness (r¼ 0.09, P¼
0.14), were correlated with 24-h diastolic BP. Significant
unadjusted correlations were noted between body weightrized reproduction of this article is prohibited.
Table 2 Correlation matrix between indices of adiposity in study
group (n U 300)
WC (cm) WHR
Mean skin-fold
thickness
Body mass index (kg/m2) 0.84MM 0.18M 0.66MM
Waist circumference (WC) (cm) – 0.58MM 0.58MM
Waist-to-hip ratio (WHR) – – 0.11y
Numbers are correlation coefficients (r). MP<0.01; MMP<0.0001 for the
relationships; yP¼0.058.
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Fig. 1
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Relationships between indices of adiposity and conventional systolic blood pressure (SBP) in study subjects (n¼300). BMI, body mass index;
WHR, waist-to-hip ratio.and conventional BP (SBP: r¼ 0.29, P< 0.0001; DBP:
r¼ 0.32, P< 0.0001), 24-h BP (SBP: r¼ 0.20, P¼ 0.0005;
DBP: r¼ 0.16, P¼ 0.0052), daytime BP (SBP: r¼ 0.20,
P¼ 0.0005; DBP: r¼ 0.15, P¼ 0.011), and night-time BP
(SBP: r¼ 0.18, P¼ 0.0016; DBP: r¼ 0.18, P¼ 0.0019).
The unadjusted associations between indices of adiposity
and BP in the subgroup of subjects who were not receiving
antihypertensive therapy (data not shown) were similar to
those in the group of subjects with ambulatory BP.
Conventional and ambulatory blood pressure and
indices of adiposity in separate models
When considering indices of adiposity in separate
regression models, but adjusting for other confounders,
BMI, WC and skin-fold thickness were independent pre-
dictors of conventional systolic and diastolic BP, whereas
waist-to-hip ratio was only associated with conventional
diastolic BP (Table 3). Waist circumference was the
only index of adiposity associated with 24-h systolic
and diastolic BP after adjustments for other covariatesopyright © Lippincott Williams & Wilkins. Unauth(Table 3). Nevertheless, the relationship between BMI
and 24-h systolic BP was close to significant (Table 3).
Analyses of daytime and night-time systolic and diastolic
BP revealed similar results, with WC being the only
index of adiposity associated after adjustments for other
covariates (Table 3). Similar results were observed in the
subgroup of subjects not receiving antihypertensive
therapy (data not shown).
Although body weight was associated with conventional
BP (systolic BP: partial r¼ 0.10, P¼ 0.03; diastolic BP:
partial r¼ 0.21, P< 0.0001), no associations with 24-h,
daytime or night-time systolic and diastolic BP were
noted after adjustments for other covariates.
Conventional and ambulatory blood pressure and
indices of adiposity in the same model
The independent relationship between WC and either
conventional or 24-h BP (Table 3) persisted after BMI,
waist-to-hip ratio and skin-fold thickness were included inorized reproduction of this article is prohibited.
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Relationships between indices of adiposity and 24-h ambulatory systolic blood pressure (SBP) in study subjects (n¼300). BMI, body mass index;
WHR, waist-to-hip ratio.
Table 3 Partial correlation coefficients (r) for the relationship between indices of adiposity considered separately in the regression model
and systolic (SBP) or diastolic blood pressure (DBP) in the study group (n U 300)
Partial ra P valuea Partial ra P valuea Partial ra P valuea Partial ra P valuea
Conventional SBP
(mmHg) 24-h SBP (mmHg) Daytime SBP (mmHg)
Night-time SBP
(mmHg)
Waist circumference (cm) 0.13 <0.005 0.14 0.009 0.14 0.009 0.11 0.031
Body mass index (kg/m2) 0.13 <0.01 0.10 0.054 0.09 0.098 0.09 0.088
Waist-to-hip ratio 0.05 0.255 0.08 0.107 0.10 0.055 0.08 0.151
Mean skin-fold thickness (cm) 0.12 <0.01 0.05 0.373 0.05 0.332 0.03 0.606
Conventional DBP
(mmHg) 24-h DBP (mmHg) Daytime DBP (mmHg)
Night-time DBP
(mmHg)
Waist circumference (cm) 0.41 <0.0001 0.12 0.033 0.13 0.018 0.11 0.048
Body mass index (kg/m2) 0.21 <0.0001 0.06 0.231 0.06 0.314 0.06 0.237
Waist-to-hip ratio 0.12 0.029 0.08 0.162 0.10 0.062 0.09 0.115
Mean skin-fold thickness (cm) 0.17 0.002 0.02 0.675 0.03 0.637 0.03 0.584
The P values indicated in bold are significant. a From stepwise regression analysis including indices of adiposity considered separately and age, gender, alcohol and
tobacco intake, postmenopausal status (confirmed with follicle stimulating hormone measurements), the presence or absence of diabetes mellitus or inappropriate blood
glucose control, and the use of antihypertensive therapy in the regression model.
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Partial correlation coefficients (r) and 95% confidence intervals for the relationship between indices of obesity and conventional (BPc) or 24-h
(BP24) systolic and diastolic blood pressure after including all indices of adiposity together in the regression equation. Partial correlation coefficients
are after adjustments for other confounders (see Table 3 for additional confounders) in the study group (n¼300, left panels) and in the subgroup not
receiving antihypertensive therapy (untreated subjects, n¼237, right panels). BMI, body mass index; skin-fold, skin-fold thickness; WC, waist
circumference; WHR, waist-to-hip ratio. P values are for significant independent relationships.the model (Fig. 3, left panels). In contrast, neither BMI nor
skin-fold thickness were significantly associated with
clinic or 24-h BP after adjusting for WC and waist-to-
hip ratio (Fig. 3, left panels). Similarly, in the subgroup of
subjects not receiving antihypertensive therapy, WC was
independently related to either conventional or 24-h BP
after BMI, waist-to-hip ratio and skin-fold thickness were
included in the model (Fig. 3, right panels). In contrast,
neither BMI nor skin-fold thickness were significantly
associated with either clinic or 24-h BP after adjusting
for WC and waist-to-hip ratio (Fig. 3, right panels). In
addition, the independent relationship between WC and
either daytime or night-time BP persisted after BMI,
waist-to-hip ratio and skin-fold thickness were includedopyright © Lippincott Williams & Wilkins. Unauthin the model (in all subjects with ambulatory BP data the
partial correlation coefficients for WC and daytime SBP
were: r¼ 0.16, P¼ 0.025; daytime DBP: r¼ 0.15, P¼
0.009; night-time SBP: r¼ 0.10, P¼ 0.058; night-time
DBP: r¼ 0.12, P¼ 0.027; in subjects not receiving anti-
hypertensive therapy, the partial correlation coefficients
for WC and daytime SBP were: r¼ 0.18, P¼ 0.002; day-
time DBP: r¼ 0.14, P¼ 0.018; night-time SBP: r¼ 0.17,
P¼ 0.005; night-time DBP: r¼ 0.14, P¼ 0.015).
Predicted size effects of indexes of adiposity on
ambulatory blood pressure
The size effects of WC on 24-h ambulatory systolic BP
associated with a 15 cm (1 SD) increase in WC wereorized reproduction of this article is prohibited.
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Unadjusted (unadj.) and adjusted differences in 24-h systolic (SBP) and diastolic (DBP) blood pressure associated with one standard deviation (SD)
increase in waist circumference [WC – panels (a) and (c), SD15 cm] or body mass index [BMI – panels (b) and (d), SD7 kg/m2] in the study
group (n¼300). Alcoh, alcohol intake; Smoke, tobacco intake; Menop, menopausal status; DM, presence or absence of diabetes mellitus or
inappropriate blood glucose control; Ht-trt, hypertension treatment; Skin-fold, skin-fold thickness; WHR, waist-to-hip ratio. 	P<0.05, 		P<0.005.partially improved on after further adjusting for skin-fold
thickness, waist-to-hip ratio and BMI (Fig. 4a). Before
adjusting for BMI, waist-to-hip ratio and skin-fold thick-
ness, every 1 SD (15 cm) increase in WC resulted in a
2.46 mmHg increase in 24-h systolic BP (Fig. 4a). In
comparison, after adjusting for skin-fold thickness, BMI
and waist-to-hip ratio, every 1 SD (15 cm) increase in WC
resulted in a 4.04 mmHg increase in 24-h systolic BP
(Fig. 4a). In contrast, the size effects of BMI on 24-h
ambulatory systolic BP associated with a 7.4 kg/m2
(1 SD) increase in BMI were considerably reduced after
adjusting for WC and waist-to-hip ratio (Fig. 4b). Similarly,
before adjusting for BMI, waist-to-hip ratio and skin-fold
thickness, every 1 SD (15 cm) increase in WC resulted in a
1.55 mmHg increase in 24-h diastolic BP (Fig. 4c);
whereas, after adjusting for skin-fold thickness, BMI
and waist-to-hip ratio, every 1 SD (15 cm) increase in
WC resulted in a 4.33 mmHg increase in 24-h diastolic
BP (Fig. 4c). In contrast, the size effects of BMI on
24-h ambulatory diastolic BP associated with a 7.4 kg/m2
(1 SD) increase in BMI were considerably reduced after
adjusting for WC and waist-to-hip ratio (Fig. 4d).
The analyses in the subgroup not receiving antihyperten-
sive therapy were similar, with every 1 SD (14.7 cm)opyright © Lippincott Williams & Wilkins. Unauthoincrease in WC resulting in 2.69 and 1.57 mmHg increases
in 24-h systolic and diastolic BP, respectively, compared
to increases of 4.74 and 4.62 mmHg in 24-h systolic and
diastolic BP, respectively, after adjusting for BMI, waist-
to-hip ratio and skin-fold thickness. In contrast, the effects
of BMI on 24-h ambulatory systolic (1.96) and diastolic
(0.98) BP associated with a 6.8 kg/m2 (1 SD) increase in
BMI were considerably reduced after adjusting for WC
and waist-to-hip ratio (2.01 and 2.41 for systolic and
diastolic BP, respectively).
Discussion
The main finding of the present study is that waist
circumference is the only clinical index of adiposity that
was associated with an increased ambulatory and con-
ventional systolic and diastolic BP independent of other
indices of adiposity.
A recent large study conducted in a European population,
in which abdominal fat effects were not assessed, has
demonstrated convincingly that BMI is associated with
ambulatory BP [34]. The present study is the first con-
ducted in a relatively large, randomly selected population
sample that has explored whether the relationship
between ambulatory BP and indices of central adiposityrized reproduction of this article is prohibited.
CCentral fat and ambulatory BP Majane et al. 1805(WC and waist-to-hip ratio) are independent of other
indices of adiposity. In this regard, the relationship bet-
ween WC and 24-h BP was independent of BMI and skin-
fold thickness, whereas the relationship between BMI and
24-h BP was masked by adding WC to the regression
equation. As ambulatory BP is a better index of cardio-
vascular outcomes [22–25] and target organ effects [26]
than conventional BP values, these data support an import-
ant role for the use of WC when predicting the BP that is
more closely associated with cardiovascular outcomes and
target organ damage than conventional BP.
Prior studies conducted in small, non-random samples
have explored whether waist-to-hip ratio is associated
with ambulatory BP independent of BMI [17–21]. Some
of these studies have suggested that waist-to-hip ratio is
independently related to ambulatory BP in both adults
(n¼ 51–97) [17,18] and in 140 children [20], findings not
supported by the present study. On the other hand,
consistent with the results of the present study, some
previous studies have demonstrated that waist-to-hip
ratio is not independently associated with ambulatory
systolic or diastolic BP in 156 schoolteachers [19] and 357
untreated hypertensives [21]. The lack of a consistent
relationship between waist-to-hip ratio and ambulatory
BP may be explained by the poor relationship between
visceral fat mass and waist-to-hip ratio [35–39]. In this
regard, some studies have highlighted the critical role of
visceral fat mass in mediating BP changes [7–16].
Three possibilities may explain the independent relation-
ship between WC, but not BMI with BP in the present and
in previous [3,4] studies. First, an inconsistent relationship
between BMI and adiposity may occur, particularly in
populations of African descent [6]. Thus BMI may not
be a reliable index of adipose tissue mass in some popu-
lations. Second, as visceral fat mass may be important in
mediating BP changes [7–16], it is also possible that BMI is
not that closely related to the fat compartment that con-
tributes to BP; however, in the present study the corre-
lation coefficient between WC and BMI was remarkably
strong (r¼ 0.84). Third, the association between BMI and
BP could be tempered by the presence of a genotype that
moderates the relationship [40] or a genotype that
increases the association between WC and BP.
The lack of an independent relationship between skin-fold
thickness and BP in the present study may also be
explained by the close relationship between visceral fat
and BP [7–16]. Skin-fold thickness is an index of subcu-
taneous peripheral fat and, as indicated in the present
study, has a poor correlation with indices of central fat.
Interestingly, when indices of adiposity were considered
separately in the regression model, skin-fold thickness and
conventional systolic and diastolic BP were correlated,
whereas skin-fold thickness and ambulatory BP were
not. These data would suggest that although peripheral/opyright © Lippincott Williams & Wilkins. Unauthsubcutaneous fat is associated with resting BP, it is not
associated with ambulatory BP.
As compared to ambulatory BP, conventional BP is more
likely to reflect an increase in sympathetic activity associ-
ated with the alerting reaction [41], and sympathetic
overactivation has been shown to be associated with
obesity [42]. Thus, the closer relationship between skin-
fold thickness and conventional BP as compared to
skin-fold thickness and ambulatory BP in the present
study may be explained by an increase in sympathetic
activity associated with the measurement of conventional
BP (alerting reaction). Similarly, the closer relationship
between WC and conventional diastolic BP as compared to
WC and ambulatory diastolic BP in the present study may
also be explained by an increase in sympathetic activity
associated with the measurement of conventional BP.
The limitations of the present study include the cross-
sectional design. Moreover, more direct measures of
visceral fat (such as computed tomography) were not em-
ployed. However, the present study was not designed to
determine the impact of visceral fat on ambulatory BP, but
rather to identify which clinical index of adiposity
is independently associated with ambulatory BP. The
relatively lower proportion of males as compared to
females recruited in the present study also raises the
question as to whether the outcomes of the present study
may only apply to females. The lower sample of males
prevented us from performing gender-specific analysis
with confidence in the outcomes; however, it is well
recognized that obesity in males is more frequently accom-
panied by central rather than peripheral fat accumulation,
hence the outcomes of the present study are unlikely to be
through an effect noted only in females. As this study was
performed in a population of African ancestry with a high
prevalence of hypertension (42%) and a high proportion of
subjects who were either overweight or obese (66%), these
data may not be applicable to other populations with a
different prevalence of hypertension or obesity.
In conclusion, the present study indicates that WC is the
only clinical index of adiposity that is associated with
ambulatory and conventional systolic and diastolic BP
independent of other indices of adiposity. Therefore,
the present data suggest that WC is the index of adiposity
to use when assessing the impact of excess adiposity on
ambulatory BP, a BP measurement that is more closely
associated with cardiovascular outcomes than is conven-
tional BP.
Acknowledgements
Nuclear families were recruited in the framework of the
African Project on Genes in Hypertension, which was sup-
ported by the International Scientific and Technological
Cooperation between South Africa and Flanders (contract
number BIL 01/43), the Medical Research Council oforized reproduction of this article is prohibited.
C1806 Journal of Hypertension 2007, Vol 25 No 9South Africa, the National Research Foundation of South
Africa (Women in Research and the Thuthuka Pro-
gramme), the Carnegie Foundation and the Circulatory
Disorders Research Trust. The University Research
Council of the University of the Witwatersrand also sup-
ported this work. This study would not have been possible
without the voluntary collaboration of the participants.
We are very grateful for the excellent technical assistance
of Mthuthuzeli Kiviet, Nkele Maseko and Nomonde
Molebatsi.
There are no conflicts of interest.
References
1 Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in
obesity among US adults, 1999–2000. JAMA 2002; 288:1723–1727.
2 Bourne LT, Lambert EV, Steyn K. Where does the black population of
South Africa stand on the nutrition transition? Public Health Nutr 2002;
5:157–162.
3 Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S.
Race-ethnicity specific waist circumference cuttoffs for identifying
cardiovascular disease risk factors. Am J Clin Nutr 2005; 81:409–415.
4 Okosun IS, Cooper RS, Rotimi CN, Osotimehin B, Forrester T. Association
of waist circumference with risk of hypertension and type 2 diabetes in
Nigerians, Jamaicans and African Americans. Diabetes Care 1998;
21:1836–1842.
5 Harris MM, Stevens J, Thomas N, Schreiner P, Folsom AR. Associations of
fat distribution and obesity with hypertension in a bi-ethnic population:
The ARIC Study. Obesity Res 2000; 8:516–524.
6 Luke A, Durazo-Arvizu R, Rotimi C, Prewitt TE, Forrester T, Wilks R, et al.
Relations between body mass index and body fat in black population
samples from Nigeria, Jamaica, and the United States. Am J Epidemiol
1997; 45:620–628.
7 Williams PT, Fortmann SP, Terry RB, Garay SC, Vrazinan KM, Ellsworth N,
Wood PD. Associations of dietary fat, regional adiposity and blood
pressure in men. JAMA 1987; 257:3251–3256.
8 Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR,
Gustafson AB, Kissebah AH. Adiposity, fat distribution and cardiovascular
risk. Ann Intern Med 1989; 110:867–872.
9 Kanai H, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Nagai Y, et al.
Close correlation of intra-abdominal fat accumulation to hypertension in
obese women. Hypertension 1990; 16:484–490.
10 Raison JM, Achimastos AM, Safar ME. Sex-dependence of body fat
distribution in patients with obesity and hypertension. Clin Exp Hypertens
1992; 14:505–525.
11 Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY.
Visceral adiposity, fasting plasma insulin and blood pressure in
Japanese-Americans. Diabetes Care 1995; 18:174–181.
12 Lerario AC, Bosco A, Rocha M, Santomaura AT, Luthold W, Giannella D,
Wajchenberg BL. Risk factors in obese women, with particular reference to
visceral fat component. Diabetes Metab 1997; 23:68–74.
13 Okosun IS, Prewitt TE, Cooper RS. Abdominal obesity in the United States:
prevalence and attributable risk of hypertension. J Hum Hypertens 1999;
13:425–430.
14 Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED. Association
between simple anthropometric indices and cardiovascular risk factors.
Int J Obes Relat Metab Disord 2001; 25:1689–1697.
15 Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE,
Fujimoto WY. Visceral adiposity and the prevalence of hypertension in
Japanese Americans. Circulation 2003; 108:1718–1723.
16 Ding J, Visser M, Kritchevsky AB, Nevitt M, Sutton-Tyrrell K, Harris TB.
The association of regional fat depots with hypertension in older persons of
white and African American ethnicity. Am J Hypertens 2004; 7:971–976.
17 Guagnano MT, Merlitti D, Murri R, Palliti VP, Sensei S. Ambulatory blood
pressure monitoring in evaluating the relationship between obesity and
blood pressure. J Hum Hypertens 1994; 8:245–250.
18 Guagnano MT, Ballone E, Merlitti D, Murri R, Pace-Palitti V, Pilotti R,
Sensei S. Association between anthropometric and ultrasound
measurements of fatness with ambulatory blood pressure monitoring
in obese women. Int J Obes Relat Metab Disord 1997; 21:632–636.
19 Steptoe A, Cropley M, Griffith J, Joekes K. The influence of abdominal
obesity and chronic work stress on ambulatory blood pressure in men and
women. Int J Obes Relat Metab Disord 1999; 23:1184–1191.opyright © Lippincott Williams & Wilkins. Unautho20 Lurbe E, Alvarez V, Liao Y, Tacons J, Cooper R, Cremades B, et al. The
impact of obesity and body fat distribution on ambulatory blood pressure in
children and adolescents. Am J Hypertens 1998; 11:418–424.
21 Feldstein CA, Akopian M, Olivieri AO, Krmer AP, Nasi M, Garrido D.
A comparison of body mass index and waist-to-hip ratio as indicators
of hypertension risk in an urban Argentine population: A hospital study.
Nutr Metab Cardiovasc Dis 2005; 15:310–315.
22 Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M,
et al. Ambulatory blood pressure. An independent predictor of prognosis in
essential hypertension. Hypertension 1994; 24:793–801.
23 Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, DuPrez DA,
Fagard RH, et al. Office versus ambulatory pressure study investigators.
Prognostic value of ambulatory blood-pressure recordings in patients with
treated hypertension. N Engl J Med 2003; 348:2407–2415.
24 Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW,
et al. Predicting cardiovascular risk using conventional versus ambulatory
blood pressure in older patients with systolic hypertension. Systolic
Hypertension in Europe Trial Investigators. JAMA 1999; 282:539–546.
25 Okhubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S.
Reference values for 24-h ambulatory blood pressure monitoring based
on prognostic criteria: the Ohasama Study. Hypertension 1998; 32:
255–259.
26 Mancia G, Parati G. Ambulatory blood pressure monitoring and organ
damage. Hypertension 2000; 36:894–900.
27 Shiburi CP, Staessen JA, Maseko M, Wojciechowska W, Thijs L, van Bortel
LM, et al. Reference values for Sphygmocor measurements in South
Africans of African ancestry. Am J Hypertens 2006; 19:40–46.
28 Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for
the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin
levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using
Glycated Hemoglobin Levels. JAMA 1996; 276:1246–1252.
29 Maseko MJ, Majane HO, Milne J, Norton GR, Woodiwiss AJ. Salt intake in
an urban, developing South African community. Cardiovasc J South Afr
2006; 17:186–191.
30 Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A.
Salt intake and blood pressure in the general population: a controlled
intervention trial in two towns. J Hypertens 1988; 6:965–973.
31 O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al.,
European Society of Hypertension Working Group on Blood Pressure
Monitoring. European Society of Hypertension recommendations for
conventional, ambulatory and home blood pressure measurement.
J Hypertens 2003; 21:821–848.
32 Thijs L, Staessen J, Fagard R. Analysis of the diurnal blood pressure curve.
High Blood Press Cardiovasc Prev 1992; 1:17–28.
33 Fagard RH, Staessen JA, Thijs L. Optimal definition of daytime and
night-time blood pressure. Blood Press Monit 1997; 2:315–321.
34 Kotsis V, Stabouli S, Bouldin M, Low SA, Toumanidis S, Zakopoulos N.
Impact of obesity on 24-h ambulatory blood pressure and hypertension.
Hypertension 2005; 45:602–607.
35 Kvist H, Chowhury B, Grangard U, Tylen U, Sjostrom L. Total and visceral
adipose tissue volumes derived from measurements with computed
tomography in adult men and women: predictive equations. Am J Clin Nutr
1988; 48:1351–1361.
36 Seidell JC, Ossterlee A, Deurenberg P, Hautvast JG, Ruijs JH. Abdominal
fat depots measured with computer tomography: effects of degree of
obesity, sex, and age. Eur J Clin Nutr 1988; 42:805–815.
37 Pouliot MC, Despres JP, Lemeeux S, Moorjani S, Bouchard C, Tremblay A,
et al. Waist circumference and abdominal sagittal diameter: best simple
anthropometric index of abdominal visceral adipose tissue accumulation
and related cardiovascular risk in men and women. Am J Cardiol 1994;
73:460–468.
38 Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation
to the metabolic syndrome. Endocrine Reviews 2000; 21:697–738.
39 Stewart KJ, DeRegis JR, Turner KL, Bacher AC, Sung J, Hees PS, et al.
Usefulness of anthropometrics and dual energy X-ray absorptiometry for
estimating abdominal obesity measured by magnetic resonance imaging in
older men and women. J Cardiopulm Rehab 2003; 23:109–114.
40 Tiago AD, Samani NJ, Candy GP, Brooksbank R, Libhaber EN, Sareli P,
et al. Angiotensinogen gene promoter region variant modifies body
size–ambulatory blood pressure relations in hypertension. Circulation
2003; 106:1483–1487.
41 Weber MA, Neutel JM, Smith DHG, Graettinger WF. Diagnosis of mild
hypertension by ambulatory blood pressure monitoring. Circulation 1994;
90:2291–2298.
42 Tentolouris N, Liatis S, Katsilambros N. Part II. Central stress activity and
peripheral tissue sensitivity in the genesis of obesity and the metabolic
syndrome: sympathetic system activity in obesity and metabolic syndrome.
Ann NY Acad Sci 2006; 1083:1289–2152.rized reproduction of this article is prohibited.
